GB
Growth N V Biotech
10% Owner

Growth N V Biotech insider trades: Black Diamond Therapeutics (BDTX) stock buys and sales

10% Owner, Black Diamond Therapeutics Last trade Mar 19, 2025 71 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
65
Open-market trades
since 2014
4
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Growth reports to the SEC

Open-market buys and sales

65 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 19, 2025BDTX↓ Sell$12.0M
Nov 1, 2024EPIX↓ Sell$12.0M
Oct 17, 2023BDTX↑ Buy$934K
Jun 30, 2023BDTX↑ Buy$5.0M
Jun 27, 2023BDTX↑ Buy$9.6M
Oct 31, 2022BDTX↑ Buy$225K
Oct 28, 2022BDTX↑ Buy$736K
Oct 27, 2022EPIX↑ Buy$8.2M
Oct 21, 2022BDTX↑ Buy$133K
Oct 20, 2022BDTX↑ Buy$179K
Jul 18, 2022EPIX↑ Buy$947K
Jul 15, 2022EPIX↑ Buy$1.7M
Apr 28, 2022BDTX↑ Buy$1.1M
Apr 27, 2022EPIX↓ Sell$147K
Apr 19, 2022BDTX↑ Buy$981K
Apr 13, 2022BDTX↑ Buy$880K
Aug 18, 2021EPIX↑ Buy$2.2M
Nov 6, 2019RDUS↑ Buy$2.3M
Dec 20, 2018RDUS↑ Buy$869K
Dec 14, 2018RDUS↑ Buy$938K
Aug 20, 2018RDUS↑ Buy$1.2M
Aug 15, 2018RDUS↑ Buy$3.5M
Aug 8, 2018RDUS↑ Buy$1.4M
Jul 27, 2018RDUS↑ Buy$1.2M
Jul 25, 2018RDUS↑ Buy$1.4M
Jun 11, 2018RDUS↑ Buy$1.4M
May 23, 2018RDUS↑ Buy$1.2M
May 21, 2018RDUS↑ Buy$1.8M
Apr 19, 2018RDUS↑ Buy$1.4M
Apr 5, 2018RDUS↑ Buy$1.8M
Mar 2, 2018RDUS↑ Buy$2.6M
Feb 9, 2018RDUS↑ Buy$2.6M
Nov 14, 2017RDUS↑ Buy$1.3M
Nov 3, 2017RDUS↑ Buy$1.5M
Oct 26, 2017RDUS↑ Buy$1.5M
Oct 25, 2017RDUS↑ Buy$1.6M
Sep 14, 2017RDUS↑ Buy$5.0M
Sep 12, 2017RDUS↑ Buy$1.8M
Sep 5, 2017RDUS↑ Buy$1.8M
Aug 16, 2017RDUS↑ Buy$2.2M
Aug 10, 2017RDUS↑ Buy$5.2M
May 30, 2017RDUS↑ Buy$1.4M
May 25, 2017RDUS↑ Buy$1.5M
May 18, 2017RDUS↑ Buy$1.7M
May 17, 2017RDUS↑ Buy$1.2M
May 12, 2017RDUS↑ Buy$510K
May 9, 2017RDUS↑ Buy$1.8M
May 8, 2017RDUS↑ Buy$1.5M
May 2, 2017RDUS↑ Buy$2.5M
May 1, 2017RDUS↑ Buy$5.3M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Growth N V Biotech's insider trades

Growth N V Biotech is a 10% owner of Black Diamond Therapeutics (BDTX). Since Jun 6, 2014, Growth has reported 62 open-market purchases worth $153.1M and 3 sales worth $24.2M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (5 filings), option exercises (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BDTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.